Bharath Bhatt

Bharath Bhatt leads AI-driven drug discovery research with expertise in generative models for de novo molecular design. His work applies variational autoencoders, transformers, and diffusion models to generate novel chemical structures with desired pharmacological properties against cancer targets. He participates in end-to-end AI drug discovery pipelines from target identification through candidate generation and optimization. His research contributes to the emerging field of fully autonomous drug discovery and has produced cancer-relevant small molecule candidates that entered preclinical development.